Ryan Bethencourt is a scientist, entrepreneur, and biohacker best known for his work as program director and venture partner at Indie.Bio, a biology accelerator and early stage seed fund. Bethencourt was head of life sciences at the XPRIZE foundation, a co-founder and CEO of Berkeley Biolabs, a biotech accelerator, and Halpin Neurosciences, an ALS therapeutics-focused biotech company. Bethencourt co-founded Counter Culture Labs, a citizen science nonprofit, and Sudo Room, a hacker space based in downtown Oakland, California.
Ryan is working to accelerate innovations in biotechnology and medicine through collaborative R&D, biohacking and open innovation. He has had extensive experience with clinical development from IND through to FDA approval, biotech fundraising and biotech business development.
Ryan prides himself on disrupting the current status quo in both medical and consumer biotech. He was previously the Life Sciences head at the XPRIZE Foundation, the co-founder and CEO of Berkeley Biolabs and the co-founder of Sudo Roomand Counter Culture Labs, where he still retains a board seat.
Ryan has worked over the last decade in the biopharmaceutical industry to partner on and develop novel drugs from first IND submission to FDA approval with many major biopharmas including Pfizer, AZ, J&J, Sanofi, Takeda, Amgen, Genentech, and other companies in the U.S., E.U., and Japan. He’s also served as COO at Genescient Pharmaceuticals, a longevity focused biotech startup and CEO of Halpin Neurosciences, an ALS focused startup. Ryan’s work has been featured in Wired, TechCrunch, Forbes, the San Francisco Business Times, and other publications. He regularly speaks on biotech innovation and writes for Biocoder, an O’Reilly Media publication.